Skip to main content
Log in

Biologicals for limited periods cost effective in Crohn's disease

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Bodger K, Kikuchi T, Hughes D.Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Alimentary Pharmacology and Therapeutics 30: 265-274, No. 3, 1 Aug 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biologicals for limited periods cost effective in Crohn's disease. Pharmacoecon. Outcomes News 586, 6 (2009). https://doi.org/10.2165/00151234-200905860-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905860-00015

Keywords

Navigation